Abstract
Background
Prescription is a complex challenge facing clinicians caring for elderly inpatients. Potentially inappropriate medication (PIM) use frequently leads to adverse drug events and geriatric syndromes. Strategies to reduce PIM use are thus urgently needed.
Objectives
The objectives of this study were to assess (1) the applicability of a pharmacist–physician intervention model to reduce the use of high-risk medications; and (2) the clinical relevance of the alerts generated by a computerized alert system (CAS).
Methods
The study was conducted in patients aged 65 years or older admitted to a teaching hospital between April and June 2014. In the intervention model, the pharmacist determined the clinical relevance of the Beers criteria-based CAS alerts, analyzed the patient’s pharmacotherapy, and developed a geriatric pharmacotherapeutic plan to be discussed with the treating physician. The main outcome was the change rate, defined as the number of patient-days with a change in at least one medication out of the number of patient-days with a pharmacist intervention.
Results
The CAS identified at least one alert in 200 patient-days, i.e., 4.3 % of screened patient-days. In 74.5 % of those patient-days, at least one alert was judged to be clinically relevant. The change rate was 77.7 %. The most frequent changes were drug discontinuation (42.4 %) and dose reduction (29.1 %). The inpatient geriatric consultation team was involved in only 24 % of the hospitalizations with at least one change in medication.
Conclusion
The intervention model reduced high-risk medication use in older inpatients. Most of the vulnerable inpatients identified by CAS alerts would not have otherwise had a geriatric medication review.
References
Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46–54.
Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003;78(12):1564–77.
Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PloS One. 2009;4(2):e4439.
Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22(5):375–92.
Ahmed S, Leurent B, Sampson EL. Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis. Age Ageing. 2014;43(3):326–33.
Corsonello A, Pedone C, Lattanzio F, et al. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc. 2009;57(6):1007–14.
Gray SL, Sager M, Lestico MR, et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci. 1998;53A(1):M59–64.
Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911–22.
Klopotowska JE, Wierenga PC, Stuijt CC, et al. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PloS One. 2013;8(8):e71045.
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.
O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485–96.
Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–7.
Page RL 2nd, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4(4):297–305.
Onder G, Landi F, Cesari M, et al. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol. 2003;59(2):157–62.
Laroche ML, Charmes JP, Nouaille Y, et al. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23(1):49–59.
Liu CL, Peng LN, Chen YT, et al. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study. Arch Gerontol Geriatr. 2012;55(1):148–51.
Jano E, Aparasu RR. Healthcare outcomes associated with beers’ criteria: a systematic review. Ann Pharmacother. 2007;41(3):438–47.
Page RL 2nd, Linnebur SA, Bryant LL, et al. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.
Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.
Hill-Taylor B, Sketris I, Hayden J, et al. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–72.
Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck®). Drugs Aging. 2013;30(10):821–8.
Peterson JF, Kripalani S, Danciu I, et al. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc. 2014;62(11):2148–52.
O’Sullivan D, O’Mahony D, O’Connor MN, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–81.
Approche adaptée à la personne âgée, cadre de référence. MSSS. 2011. http://publications.msss.gouv.qc.ca/acrobat/f/documentation/2010/10-830-03.pdf. Accessed 14 July 2015.
Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275(11):852–7.
Martinez JA, Belastegui A, Basabe I, et al. Derivation and validation of a clinical prediction rule for delirium in patients admitted to a medical ward: an observational study. BMJ Open. 2012;2(5):e001599. doi:10.1136/bmjopen-2012-001599.
Kanagaratnam L, Mahmoudi R, Novella JL, et al. Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit. Drugs Aging. 2014;31(10):769–76.
Terrell KM, Perkins AJ, Dexter PR, et al. Computerized decision support to reduce potentially inappropriate prescribing to older emergency department patients: a randomized, controlled trial. J Am Geriatr Soc. 2009;57(8):1388–94.
Mattison ML, Afonso KA, Ngo LH, et al. Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med. 2010;170(15):1331–6.
Peterson JF, Kuperman GJ, Shek C, et al. Guided prescription of psychotropic medications for geriatric inpatients. Arch Intern Med. 2005;165(7):802–7.
Clyne B, Bradley MC, Hughes C, et al. Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence. Clin Geriatr Med. 2012;28(2):301–22.
Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother. 2008;6(2):119–29.
World Health Organization. International Classification of diseases 10th edition. Version 2015. http://apps.who.int/classifications/icd10/browse/2015/en. Accessed 14 July 2015.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.
Canadian Institute for Health Information. Hospital Standardized Mortality Ratio (HSMR). 2014. http://www.cihi.ca/CIHI-ext-portal/pdf/internet/HSMR_TECH_NOTES_EN. Accessed 14 July 2015.
Acknowledgments
The authors are grateful to Guillaume Joly for his help in developing and structuring the CAS, and to Mathieu Caron and Philip-André Fillion for their informatics support.
Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, Anne-Sophie Michaud, Josée Bergeron, Louise Mallet, Serge Brazeau, Thomas Joly-Mischlich, Nora Bernier-Filion, and Benoit Cossette designed the study; Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, Anne-Sophie Michaud, Josée Bergeron, Louise Mallet, Thomas Joly-Mischlich, Nora Bernier-Filion, and Benoit Cossette acquired and analyzed the data; Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, Anne-Sophie Michaud, Josée Bergeron, Louise Mallet, Serge Brazeau, Thomas Joly-Mischlich, Nora Bernier-Filion, Luc Lanthier, Geneviève Ricard, Marie-Claude Rodrigue, and Benoit Cossette interpreted the data; Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, Anne-Sophie Michaud, Josée Bergeron, Louise Mallet, and Benoit Cossette drafted the manuscript; Serge Brazeau, Thomas Joly-Mischlich, Nora Bernier-Filion, Luc Lanthier, Geneviève Ricard, and Marie-Claude Rodrigue critically revised the manuscript. The first four authors (Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, and Anne-Sophie Michaud) were completing a clinical Master graduate program in advanced pharmacotherapy (hospital) during the conduct of the study and contributed equally to the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded partially through a grant received from the Fonds Brigitte-Perreault of the CHUS Foundation. The funding source had no involvement in the study design, data collection, analysis, or interpretation; the writing of the report; or the decision to submit the report for publication.
Conflict of interest
Karolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, Anne-Sophie Michaud, Josée Bergeron, Louise Mallet, Serge Brazeau, Thomas Joly-Mischlich, Nora Bernier-Filion, Luc Lanthier, Geneviève Ricard, Marie-Claude Rodrigue, and Benoit Cossette declare they have no conflicts of interest that are directly relevant to the content of this study.
Ethical approval
This study was approved by the Centre hospitalier universitaire de Sherbrooke Research Ethics Committee.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arvisais, K., Bergeron-Wolff, S., Bouffard, C. et al. A Pharmacist–Physician Intervention Model Using a Computerized Alert System to Reduce High-Risk Medication Use in Elderly Inpatients. Drugs Aging 32, 663–670 (2015). https://doi.org/10.1007/s40266-015-0286-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-015-0286-5